Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area pi3k akt signaling pi3k inhibitors'

Search results for: 'research area pi3k akt signaling pi3k inhibitors'

Items 1-10 of 59

Page
per page
  1. Tie2 kinase inhibitor
    A5979 Tie2 kinase inhibitor
    Target: Tie-2
    Summary: Tie-2(Tie2 ) inhibitor
      ≥22 mg/mL
  2. Sorafenib
    A3009 Sorafenib
     2 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥23.25 mg/mL
  3. Gefitinib hydrochloride
    A3433 Gefitinib hydrochloride
    Target: EGFR
    Summary: Potent EGFR inhibitor
      insoluble in EtOH; ≥4.28 mg/mL
  4. Nintedanib (BIBF 1120)
    A8252 Nintedanib (BIBF 1120)
     3 Citation
    Target: VEGFR|PDGFR|FGFR
    Summary: VEGFR/PDGFR/FGFR inhibitor
      insoluble in H2O; insoluble in EtOH; ≥5.34 mg/mL
  5. AG-490
    A4139 AG-490
     3 Citation
    Target: EGFR|JAK
    Summary: JAK2/EGFR inhibitor
      insoluble in H2O; ≥14.7 mg/mL
  6. LY2801653
    A3573 LY2801653
    Target: MET
    Summary: MET inhibitor
      ≥27.65 mg/mL
  7. GNF 5
    A8604 GNF 5
    Target: Bcr-Abl
    Summary: Bcr-Abl inhibitor
  8. GW441756
    B2297 GW441756
     1 Citation
    Target: Trk Receptors
    Summary: TrkA inhibitor,potent and selective
      insoluble in H2O; insoluble in EtOH; ≥13.75 mg/mL
  9. PP 1
    A8215 PP 1
    Target: Src|EGFR|JAK|ZAP-70
    Summary: Src family tyrosine kinase inhibitor
  10. Lapatinib
    A8218 Lapatinib
     2 Citation
    Target: ErbB
    Summary: EGFR/HER2 inhibitor,potent,selective and reversible
      ≥29.05 mg/mL

Items 1-10 of 59

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
  2. Specificity Selective Remove This Item
  3. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 2item
  2. Axl 3item
  3. ALK 1 item
  4. c-FMS 1 item
  5. c-Kit 1 item
  6. c-MET 8item
  7. c-RET 1 item
  8. CSF-1R 2item
  9. EGFR 9item
  10. FAK 2item
  11. FGFR 2item
  12. FLT3 2item
  13. HER2 3item
  14. IGF1R 3item
  15. ITK 1 item
  16. LRRK2 3item
  17. PDGFR 6item
  18. Pyk2 1 item
  19. Spleen Tyrosine Kinase (Syk) 3item
  20. Src 3item
  21. Tie-2 2item
  22. Trk 2item
  23. VEGFR 8item
Reversibility
  1. Reversible 4item
  2. Irreversible 1 item
Target
  1. Raf 2item
  2. CSF-1R 2item
  3. MER 1 item
  4. FLT3 6item
  5. Eph Receptors 1 item
  6. VEGFR 13item
  7. PDGFR 8item
  8. c-Kit 3item
  9. RET 1 item
  10. Bcr-Abl 3item
  11. FGFR 2item
  12. MET 5item
  13. Src 3item
  14. Trk Receptors 2item
  15. EGFR 9item
  16. FAK 2item
  17. JAK 2item
  18. Syk 3item
  19. ErbB 1 item
  20. c-MET 6item
  21. Pyk2 2item
  22. LRRK2 3item
  23. Insulin and Insulin-like Receptors 2item
  24. ALK 1 item
  25. Tie-2 2item
  26. Ron 1 item
  27. Insulin Receptors 1 item
  28. IRG-1R 1 item
  29. ZAP-70 1 item
  30. Flk-1 1 item
  31. TAM kinase 1 item
  32. AXL 1 item
  33. c-Fms tyrosine kinase 1 item
  34. ITK 1 item
  35. DCLK2 1 item
  36. tropomyosin receptor kinase 1 item
  37. Insulin Receptor 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 3item
  3. Adrenocortical Carcinoma 1 item
  4. Bladder Cancer 3item
  5. Bladder Carcinoma 1 item
  6. Breast Cancer 11item
  7. Cancer 41item
  8. Cervical Cancer 1 item
  9. Cholangiocarcinoma 1 item
  10. Clear Cell Renal Cell Carcinoma 1 item
  11. Colon Cancer 3item
  12. Colon Carcinoma 1 item
  13. Colorectal Cancer 8item
  14. Glioblastoma 6item
  15. Glioma 1 item
  16. Hepatocellular Carcinoma 3item
  17. Leukemia 1 item
  18. Liver Cancer 2item
  19. Lung Cancer 3item
  20. Lung Carcinoma 2item
  21. Lymphoma 4item
  22. Melanoma 1 item
  23. Multiple Myeloma 2item
  24. Non-small Cell Lung Cancer 3item
  25. Ovarian Cancer 5item
  26. Pancreatic Cancer 9item
  27. Prostate Cancer 5item
  28. Renal Cancer 1 item
  29. Renal Cell Carcinoma 1 item
  30. Rheumatoid Arthritis 2item
  31. Thyroid Cancer 2item